Literature DB >> 10819846

Changes in hemodynamic parameters and volume homeostasis with the menstrual cycle among women with a history of preeclampsia.

M E Spaanderman1, E Van Beek, T H Ekhart, J Van Eyck, E C Cheriex, P W De Leeuw, L L Peeters.   

Abstract

OBJECTIVE: Among women with a history of preeclampsia the prevalence of hemodynamic and clotting disorders is elevated. In this study we tested the hypothesis that the normal cyclic variation in hemodynamic and renal function parameters with the menstrual cycle that is seen among healthy women would be preserved in women with a history of preeclampsia irrespective of whether they had an underlying hemodynamic or clotting disorder. STUDY
DESIGN: We compared the hemodynamic and volume cyclic variations during the menstrual cycle among women with a history of preeclampsia (n = 39) with those among healthy parous control women (control group, n = 10). The participants with a history of preeclampsia were subdivided into groups of women with hypertension with or without thrombophilia (hypertension group, n = 10), women with a normotension and a thrombophilic disorder (thrombophilia group, n = 17), and women without either of these abnormalities (symptom-free group, n = 12). We measured > or =5 months post partum, once during the follicular phase of the menstrual cycle (day 5 +/- 2) and once during the luteal phase (day 22 +/- 2), the following variables: body weight and length, mean arterial pressure, heart rate, cardiac output, plasma volume, glomerular filtration rate, effective renal plasma flow, and concentrations of renal volume homeostatic hormones, reproductive hormones, and catecholamines. From the measured data we calculated body mass index, cardiac index, left ventricular work, total peripheral and renal vascular resistances, effective renal blood flow, and renal filtration fraction.
RESULTS: The hypertension group differed from the control group in having higher baseline (follicular phase) values for cardiac output, cardiac output, left ventricular work, renal vascular resistance, and atrial natriuretic peptide and norepinephrine levels. The symptom-free group differed from the control group in having a lower baseline plasma volume and higher baseline cardiac output and left ventricular work values. Women in the thrombophilia group were comparable to those in the control group with respect to baseline hemodynamic and renal function variables except for a higher renal vascular work value. In the control group heart rate, plasma volume, effective renal plasma volume, effective renal blood flow, and concentrations of renin-angiotensin-aldosterone system hormones and norepinephrine were increased during the luteal phase with respect to values during the follicular phase, whereas the renal vascular resistance and atrial natriuretic peptide values were decreased. In the three subgroups of women with a history of preeclampsia this cyclic pattern with the menstrual cycle was preserved for most of these parameters.
CONCLUSION: Although baseline hemodynamic and volume status among women with a history of preeclampsia differed from that among healthy parous control subjects, the cyclic variation with the menstrual cycle was largely preserved.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10819846     DOI: 10.1067/mob.2000.105342

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  Long-Term Risk to Develop Hypertension in Women With Former Preeclampsia: A Longitudinal Pilot Study.

Authors:  Chahinda Ghossein-Doha; Marc Spaanderman; Sander M J van Kuijk; Abraham A Kroon; Tammo Delhaas; Louis Peeters
Journal:  Reprod Sci       Date:  2014-01-18       Impact factor: 3.060

2.  Differences in cardiovascular function comparing prior preeclamptics with nulliparous controls.

Authors:  Ira M Bernstein; Sarah A Hale; Gary J Badger; Carole A McBride
Journal:  Pregnancy Hypertens       Date:  2016-07-05       Impact factor: 2.899

Review 3.  Risk of cardiovascular disease, end-stage renal disease, and stroke in postpartum women and their fetuses after a hypertensive pregnancy.

Authors:  Mark W Cunningham; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-06-13       Impact factor: 3.619

4.  Tongue color changes within a menstrual cycle in eumenorrheic women.

Authors:  Shu-Feng Hsieh; Li-Ling Shen; Shan-Yu Su
Journal:  J Tradit Complement Med       Date:  2015-08-20

Review 5.  Why non-invasive maternal hemodynamics assessment is clinically relevant in early pregnancy: a literature review.

Authors:  Sharona Vonck; Anneleen Simone Staelens; Ine Bollen; Lien Broekx; Wilfried Gyselaers
Journal:  BMC Pregnancy Childbirth       Date:  2016-10-12       Impact factor: 3.007

6.  Plasma volume variation across the menstrual cycle among healthy women of reproductive age: A prospective cohort study.

Authors:  Sixtus Aguree; Hilary J Bethancourt; Leigh A Taylor; Asher Y Rosinger; Alison D Gernand
Journal:  Physiol Rep       Date:  2020-04

7.  A methodology for examining the association between plasma volume and micronutrient biomarker mass and concentration in healthy eumenorrheic women.

Authors:  Sixtus Aguree; Alison D Gernand
Journal:  PeerJ       Date:  2020-12-21       Impact factor: 2.984

8.  Angiotensin II type 1 receptor agonistic autoantibody blockade improves postpartum hypertension and cardiac mitochondrial function in rat model of preeclampsia.

Authors:  George W Booz; Daniel Kennedy; Michael Bowling; Taprieka Robinson; Daniel Azubuike; Brandon Fisher; Karen Brooks; Pooja Chinthakuntla; Ngoc H Hoang; Jonathan P Hosler; Mark W Cunningham
Journal:  Biol Sex Differ       Date:  2021-11-02       Impact factor: 5.027

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.